Clinical Trials
16 trialsNCT07173127 2026-04-29
The Impact of a Novel GnRH Antagonist With Add-back Therapy for Treatment of Uterine Fibroids and Endometriosis on Hemostasis Parameters
University Hospital, Geneva
Phase NA Recruiting
NCT04567771 2026-04-23
Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer
Mayo Clinic
Phase NA Recruiting
NCT07120945 2026-03-06
Embrace Gyn
Medtronic - MITG
Phase NA Recruiting
NCT04806620 2026-01-22
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Brain Inflammation Collaborative
Recruiting
NCT04154683 2026-01-15
GYNECOPTIC
Hospices Civils de Lyon
Phase NA Recruiting
NCT05726786 2025-12-09
INCyst
Centre Hospitalier Universitaire Vaudois
Phase 3 Recruiting
NCT07231510 2025-11-17
KARU-FERTIL
Centre Hospitalier Universitaire de la Guadeloupe
Recruiting
NCT07215130 2025-10-10
CUSA-ENDO
Kanazawa University
Recruiting
NCT05739123 2025-08-19
Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring
Sumitomo Pharma Switzerland GmbH
Recruiting
NCT05862272 2025-08-06
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Sumitomo Pharma Switzerland GmbH
Phase 3 Recruiting
NCT06991595 2025-05-28
REAdME
Charles University, Czech Republic
Recruiting
NCT06024109 2025-05-13
BARHYSTER
Aesculap AG
Recruiting
NCT06891690 2025-03-24
tDCS
Poznan University of Physical Education
Phase NA Recruiting
NCT02253251 2025-01-23
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
MiraKind
Recruiting
NCT06392997 2025-01-23
GynRNA
ZIWIG
Recruiting
NCT03622983 2022-12-21
PELVIMASS2
Centre Hospitalier Intercommunal Creteil
Recruiting